Publication date: 8 June 2016
Source:Vaccine, Volume 34, Issue 27
Author(s): Geert Leroux-Roels, Pierre Van Damme, Wouter Haazen, Sepehr Shakib, Magalie Caubet, Emmanuel Aris, Jeanne-Marie Devaster, Mathieu Peeters
BackgroundNon-typeable Haemophilus influenzae (NTHi) is a major cause of various respiratory diseases. The development of an effective vaccine against NTHi mandates new approaches beyond conjugated vaccines as this opportunistic bacterium is non-encapsulated. Here we report on the safety, reactogenicity and immunogenicity of a multi-component investigational vaccine based on three conserved surface proteins from NTHi (proteins D [PD], E [PE] and Pilin A [PilA]) in two observer-blind phase I studies.MethodsIn the first study (NCT01657526), 48 healthy 18–40 year-olds received two vaccine formulations (10 or 30μg of each antigen [PD and a fusion protein PE-PilA]) or saline placebo at months 0 and 2. In the second study (NCT01678677), 270 50–70 year-olds, current or former smokers, received eight vaccine formulations (10 or 30μg antigen/dose non-adjuvanted or adjuvanted with alum, AS01E or AS04C) or saline placebo at months 0, 2 and 6 (plain and alum-adjuvanted groups) and at months 0 and 2 (AS-adjuvanted groups). Solicited and unsolicited adverse events (AEs) were recorded for 7 and 30 days post-vaccination, respectively; potential immune-mediated diseases (pIMDs) and serious AEs (SAEs) throughout the studies. Humoral and antigen-specific T-cell immunity (in study 2 only) responses were assessed up to 12 months post-vaccination.ResultsObserved reactogenicity was highest in the AS-adjuvanted groups but no safety concerns were identified with any of the NTHi vaccine formulations. One fatal SAE (cardiac arrest) not considered related to vaccination, and one pIMD (non-serious psoriasis) in the Placebo group, were reported post-dose 3 in Study 2. All formulations generated a robust antibody response while the AS01-adjuvanted formulations produced the highest humoral and cellular immune responses.ConclusionThis study confirms that the NTHi vaccine formulations had an acceptable reactogenicity and safety profile and were immunogenic in adults. These results justify further clinical development of this NTHi vaccine candidate.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1ssQh85
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
-
▼
Ιουνίου
(1110)
-
▼
Ιουν 04
(49)
- A Protocol for Management of the Hairs Problem in ...
- Congenital Hypertonia of the Temporalis Leading to...
- The utility of p16 immunostaining in fine needle a...
- Real-World Effectiveness and Safety of a Live-Atte...
- Multiple efficacy studies of an adenovirus-vectore...
- Control of Ixodes ricinus and Dermacentor reticula...
- Editorial Board/Aims and Scope
- A population profile of measles susceptibility in ...
- Emergence of antigenic variants within serotype A ...
- Effect of high and low levels of maternally derive...
- Impact of enterovirus and other enteric pathogens ...
- Vaccination against H5 avian influenza virus induc...
- Immune effects of the vaccine of live attenuated A...
- Heparan sulfates targeting increases MHC class I- ...
- CRACC-targeting Fc-fusion protein induces activati...
- Immunogenicity and safety of high-dose trivalent i...
- Phase I, randomized, observer-blind, placebo-contr...
- Characterization of serum antibodies from women im...
- Up-regulation of BSEP and MRP2 by Calculus Bovis a...
- Amelioration of testosterone induced benign prosta...
- Rheumatoid arthritis onset in postmenopausal women...
- Neonatal overfeeding induces early decline of the ...
- Upregulation of long noncoding RNA LOC100507661 pr...
- Oxidative stress and the subcellular localization ...
- Estrogen receptor profiling and activity in cardia...
- Up-regulation of Hsp27 by ERα/Sp1 facilitates prol...
- Urinary metabolomic profiling in mice with diet-in...
- An analogue of atrial natriuretic peptide (C-ANP4-...
- Benzyl butyl phthalate induces epigenetic stress t...
- Fibronectin-1 expression is increased in aggressiv...
- Novel dual agonist peptide analogues derived from ...
- Expression analysis and localization of wt1, ad4bp...
- Laparoscopy-assisted distal gastrectomy for early ...
- Value Based Care and Patient-Centered Care: Diverg...
- Genome-wide association of familial prostate cance...
- Stable isotope on the evaluation of water quality ...
- Microbial disinfection of water with endotoxin deg...
- An improved biofilter to control the dissolved org...
- Combination of antibiotics suppressed the increase...
- Cultivating Chlorella vulgaris and Scenedesmus qua...
- Insight into visible light-driven photocatalytic d...
- Impact of molybdenum nanoparticles on survival, ac...
- Bioavailability of pollutants sets risk of exposur...
- Surfactant enhanced pyrene degradation in the rhiz...
- Exploitation of subabul stem lignin as a matrix in...
- Pretreatment quality of life, performance status a...
- Differential role of microRNAs in the pathogenesis...
- Hypomineralised second primary molars: prevalence,...
- The Nation and the Family: The Impact of National ...
-
▼
Ιουν 04
(49)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Σάββατο 4 Ιουνίου 2016
Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου